
USFDA APPLICATION NUMBER - 22108 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 348MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| BUPROPION HYDROBROMIDE(UNII: E70G3G5863) (BUPROPION - UNII:01ZG3TPX31) | BUPROPION HYDROBROMIDE | 522mg | 348mg | 174mg |
Inactive Ingredients
| Ingredient Name | sanofi-aventis U.S. LLC |
|---|---|
| CARNAUBA WAX(R12CBM0EIZ) | |
| DIBUTYL SEBACATE(4W5IH7FLNY) | |
| ETHYLCELLULOSE (100 MPA.S)(47MLB0F1MV) | |
| GLYCERYL DIBEHENATE(R8WTH25YS2) | |
| POLYETHYLENE GLYCOLS(3WJQ0SDW1A) | |
| POLYVINYL ALCOHOL(532B59J990) | |
| POVIDONES(FZ989GH94E) |